Survey: Blood stem cell transplants mostly done in wealthier countries

04/28/2010 | Medscape (free registration)

Hematopoietic stem cell transplantation is becoming adopted as a treatment worldwide, but its use is more common in richer countries, according to a survey by the Worldwide Network for Blood and Marrow Transplantation. The main indications for the use of the stem cell treatment were lymphoproliferative disorders and leukemias, and most of the transplants were done in Europe, the survey showed.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ